|
|
|
Volumn 13, Issue 3, 1998, Pages 163-168
|
|
Clinical usefulness of glycoprotein IIb/IIIa inhibitors;Impiego clinico degli inibitori della glicoproteina IIb/IIIa
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
LAMIFIBAN;
PLACEBO;
TIROFIBAN;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CORONARY ARTERY THROMBOSIS;
DRUG EFFICACY;
DRUG SAFETY;
FIBRINOLYTIC THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, BALLOON;
ANTIBODIES, MONOCLONAL;
FIBRINOLYTIC AGENTS;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
ISCHEMIA;
PEPTIDES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TYROSINE;
|
|
EID: 0031755246
PISSN: 03939340
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (20)
|
